ECS Botanics HoldingsASX:ECS -11.11% PB Ratio is 0.27 as of Jun. 25, 2026, which is 86% below its 10-year median of 1.98. The stock has 9 warning signs investors should review. Among 922 Drug Manufacturers companies, ECS Botanics Holdings ranks better than 96.75% on this metric.
The historical rank and industry rank for ECS Botanics Holdings's PB Ratio or its related term are showing as below:
ASX:ECS'
s PB Ratio Range Over the Past 10 Years
Min: 0.26 Med: 1.98 Max: 7.97
Current: 0.27
During the past 13 years, ECS Botanics Holdings's highest PB Ratio was 7.97. The lowest was 0.26. And the median was 1.98.
ASX:ECS's PB Ratio is ranked better than 96.75% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.855
vs ASX:ECS: 0.27
During the past 12 months, ECS Botanics Holdings's average Book Value Per Share Growth Rate was -25.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -5.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 8.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of ECS Botanics Holdings was 71.00% per year. The lowest was -73.00% per year. And the median was -11.70% per year.
Back to Basics: PB Ratio
ECS Botanics Holdings (ASX:ECS) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, ECS Botanics Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ECS Botanics Holdings PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ECS Botanics Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where ECS Botanics Holdings's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
ECS Botanics Holdings (ASX:ECS) has a PB Ratio of 0.27 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on ECS Botanics Holdings and its competitors. This is 86% below median its historical median of 1.98. Over the past decade, ECS Botanics Holdings' PB Ratio has ranged from 0.26 to 7.97. According to the industry distribution chart, ECS Botanics Holdings ranks #30 out of 922 companies in the Drug Manufacturers industry, placing it in the top 3.3%.
Is ECS Botanics Holdings' PB Ratio too high?
ECS Botanics Holdings' current PB Ratio of 0.27 is 86% below median its 10-year median of 1.98. Over the past 10 years, this metric has ranged from a low of 0.26 to a high of 7.97. The Drug Manufacturers industry median PB Ratio is 1.86. ECS Botanics Holdings' value of 0.27 is 85.4% below this industry median. Based on the distribution chart, ECS Botanics Holdings ranks #30 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does ECS Botanics Holdings' PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, ECS Botanics Holdings ranks #30 out of 922 companies for PB Ratio. This places ECS Botanics Holdings in the top 3% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.86. ECS Botanics Holdings' value of 0.27 is 85.4% below this benchmark. Historically, ECS Botanics Holdings' own PB Ratio has ranged from 0.26 to 7.97 over the past decade. While the company's 10-year median is 1.98 vs. the industry median of 1.86, ECS Botanics Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.86, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ECS Botanics Holdings's current PB Ratio of 0.27 is 85.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on ECS Botanics Holdings and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ECS Botanics Holdings's current PB Ratio is 0.27, which is 86% below median its own 10-year median of 1.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ECS Botanics Holdings stock overvalued right now?
Based on GuruFocus' analysis, ECS Botanics Holdings (ASX:ECS) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.00 — trading 80% below its estimated fair value. The current PB Ratio is 0.27, which is 86% below median its 10-year median of 1.98 and 85.4% below the Drug Manufacturers industry median of 1.86. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For ECS Botanics Holdings (ASX:ECS), the current PB Ratio is 0.27 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ECS Botanics Holdings Ltd is an Australian medicinal cannabis cultivator and manufacturer located in Northwest Victoria. The company utilizes progressive cultivation methodologies to produce quality medicine in a sustainable way, adopting regenerative and organic horticultural practices and renewable energy sources. Licensed by the Therapeutic Drug Administration to manufacture PIC/S GMP certified products, the company provides quality, affordable medicinal cannabis, supplying both local and overseas markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ECS has been successfully added to your 